Unlocking Opportunities in the Mitral Valve Disease Market: 2025-2034 Forecast Report

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Mitral Valve Disease Industry Market Size Be by 2025?
The market size for mitral valve disease has experienced substantial growth in the past few years. It is projected to rise from $3 billion in 2024 to $3.3 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.8%. The escalation in the historic period can be credited to initiatives focusing on patient education, comprehensive reimbursement policies, insurance coverage, increasing healthcare spending, heightened awareness and screening initiatives, as well as broadening market presence.

What's the Long-Term Growth Forecast for the Mitral Valve Disease Market Size Through 2029?
Anticipated robust expansion in the near future is projected for the mitral valve disease market, which is set to surge to $4.73 billion by 2029, yielding a compound annual growth rate (CAGR) of 9.4%. Factors contributing to the advancement during the projection period include the escalating prevalence of mitral valve disease, higher inclination towards minimally invasive procedures, rising innovation in heart valve surgery, and growing venture capital investments, along with the increased focus of manufacturers. The period is likely to see major trends like technological progress, enhancements in transcatheter technologies, and continual improvement in surgical techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report

What Are the Key Growth Drivers Fueling the Mitral Valve Disease Market Expansion?
The mitral valve disease market is likely to see growth due to the rise in cases of vascular heart diseases. These diseases are a collection of conditions that affect the blood vessels either supplying the heart or located within the heart. The rise in vascular heart diseases is propelled by a complex mix of lifestyle decisions, demographic shifts, medical situations, environmental influences, and genetic factors. Vascular heart diseases like ischemic heart disease and hypertension can indirectly lead to mitral valve disease by affecting the structure and functionality of the heart, thereby causing conditions that impact the mitral valve. For example, data from the Australian Institute of Health and Welfare's 2020-21 National Health Survey, quoted by the Australian Bureau of Statistics, reported that the death rate from cardiovascular disease for every 100,000 people increased from 143.7 in 2021 to 148.2 in 2022 for men in Australia. As such, the surge in cases of vascular heart diseases is fueling the growth of the mitral valve disease market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp

What Are the Key Trends Driving Mitral Valve Disease Market Growth?
Prominent companies in the mitral valve disease market are progressing stented tissue valves to meet the rising demand for minimally invasive therapeutic choices. These valves are engineered to offer lasting and dependable service, giving patients a viable alternative to traditional surgical treatments. For example, in April 2024, Medtronic, a healthcare firm based in Ireland, introduced the Avalus Ultra valve. This advanced surgical aortic tissue valve is designed for increased implantation ease and long-term patient care. Leveraging a decade of clinical knowledge with the original Avalus valve, the Avalus Ultra showcases a low valve profile for streamlined implantation, a PEEK base frame for uniform circularity, and an industry-topping Effective Orifice Area (EOA) that could enable enhanced blood flow. Moreover, it also has a radiopaque coil for easy visibility during forthcoming valve-in-valve procedures.

How Is the Mitral Valve Disease Market Segmented?
The mitral valve disease market covered in this report is segmented -

1) By Treatment Type: Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics
2) By Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Mitral Valve Repair: Surgical Repair, Minimally Invasive Repair, Percutaneous Mitral Valve Repair
2) By Mitral Valve Replacement: Mechanical Valve Replacement, Biological Valve Replacement, Transcatheter Mitral Valve Replacement (TMVR)
3) By Cardiac Resynchronization Therapy: Pacemaker Therapy, Implantable Cardioverter-Defibrillators (ICD), Biventricular Pacing
4) By Mitral Valve Therapeutics: Pharmacological Treatments, Anticoagulation Therapy, Mitral Valve Repair Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16480&type=smp

Which Companies Are Leading the Charge in Mitral Valve Disease Market Innovation?
Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH

Which Regions Are Leading the Global Mitral Valve Disease Market in Revenue?
Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16480

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.